87 phenotypes from multigenic genotypes

Allelic Composition Genetic Background	Annotated Term	Reference
ApcMin/Apc+ EgfrWa5/Egfr+ involves: BALB/cAnN * C3H/HeN * C57BL/6J	decreased tumor incidence	J:92308
Chuktm1Yhu/Chuktm1Yhu Egfrtm1Mag/Egfr+ Tg(KRT5-cre)5132Jlj/0 involves: 129 * C57BL/6 * CD-1	abnormal coat/ hair morphology	J:141162
	abnormal eye morphology	J:141162
	decreased survivor rate	J:141162
	premature death	J:141162
	thick epidermis	J:141162
Chuktm1Yhu/Chuktm1Yhu Egfrtm1Mag/Egfrtm1Mag Tg(KRT5-cre)5132Jlj/0 involves: 129 * C57BL/6 * CD-1	postnatal lethality, complete penetrance	J:141162
Chuktm1Yhu/Chuktm1Yhu Egfrwa2/Egfrwa2 Tg(KRT5-cre)5132Jlj/0 involves: 129S1/Sv * 129X1/SvJ * C57BL/6	abnormal epidermal layer morphology	J:141162
	normal integument phenotype	J:141162
	premature death	J:141162
Egfrtm1Wag/Egfrtm2(EGFR)Wag involves: 129	prenatal lethality, complete penetrance	J:84870
Egfrtm1Wag/Egfrtm2(EGFR)Wag involves: 129/Sv * C57BL/6	prenatal lethality, complete penetrance	J:84870
Egfrtm2(EGFR)Wag/Egfrtm2(EGFR)Wag involves: 129	prenatal lethality, complete penetrance	J:84870
Egfrtm2(EGFR)Wag/Egfrtm2(EGFR)Wag involves: 129/Sv * C57BL/6	abnormal hair cycle	J:84870
	abnormal hair follicle orientation	J:84870
	abnormal semilunar valve morphology	J:84870
	alopecia	J:84870
	cardiac hypertrophy	J:84870
	curly vibrissae	J:84870
	decreased body size	J:84870
	decreased body weight	J:84870
	decreased hair follicle number	J:84870
	delayed hair appearance	J:84870
	enhanced osteoblast differentiation	J:84870
	heart left ventricle hypertrophy	J:84870
	normal nervous system phenotype	J:84870
	postnatal growth retardation	J:84870
	premature chondrocyte differentiation	J:84870
	premature death	J:84870
	prenatal lethality, incomplete penetrance	J:84870
	short hair	J:84870
	sparse hair	J:84870
Egfrwa2/Egfr+ Nf1tm1Fcr/Nf1+ Trp53tm1Brd/Trp53+ involves: 129S/SvEv * 129S7/SvEvBrd * C57BL/6 * C57BL/6JEi * C3H/HeSnJ	decreased tumor incidence	J:95933
Egfrwa2/Egfr+ Fostm2(Fosl1)Wag/Fostm2(Fosl1)Wag Tg(KRT5-SOS1)892A6Wag/0 involves: 129P2/OlaHsd * C57BL/6 * CBA	decreased tumor growth/size	J:175064
	increased skin papilloma incidence	J:175064
Egfrwa2/Egfr+ Rps6ka3tm1.1Kry/Y Tg(KRT5-SOS1)892A6Wag/0 involves: 129X1/SvJ * C57BL/6 * CBA	decreased tumor growth/size	J:175064
	increased skin papilloma incidence	J:175064
Egfrwa2/Egfr+ Errfi1tm1Kln/Errfi1tm1Kln involves: 129P2/OlaHsd * C3H/HeSnJ * C57BL/6	abnormal skin morphology	J:109556
Egfrwa2/Egfr+ Fostm3.1Wag/Fostm3.1Wag Tg(KRT5-SOS1)892A6Wag/0 involves: 129P2/OlaHsd * C57BL/6 * CBA * SJL	decreased tumor growth/size	J:175064
	increased skin papilloma incidence	J:175064
Egfrwa2/Egfr+ Fostm4.1Wag/Fostm4.1Wag Tg(KRT5-SOS1)892A6Wag/0 involves: 129P2/OlaHsd * C57BL/6 * CBA	increased skin papilloma incidence	J:175064
Egfrwa2/Egfr+ Fostm5.1Wag/Fostm5.1Wag Tg(KRT5-SOS1)892A6Wag/0 involves: 129P2/OlaHsd * C57BL/6 * CBA * SJL	decreased tumor growth/size	J:175064
	increased skin papilloma incidence	J:175064
	increased skin tumor incidence	J:175064
Egfrwa2/Egfr+ Fostm6.1Wag/Fostm6.1Wag Tg(KRT5-SOS1)892A6Wag/0 involves: 129P2/OlaHsd * C57BL/6 * CBA * SJL	increased skin papilloma incidence	J:175064
	increased tumor growth/size	J:175064
Egfrwa2/Egfr+ Tg(KRT5-SOS1)892A6Wag/0 involves: C57BL/6 * CBA	increased skin papilloma incidence	J:175064
	increased skin tumor incidence	J:175064
Egfrwa2/Egfrwa2 Eregtm1Dwt/Eregtm1Dwt involves: 129S6/SvEvTac	no abnormal phenotype detected	J:93327
Egfrwa2/Egfrwa2 Errfi1tm1Kln/Errfi1tm1Kln involves: 129P2/OlaHsd * C3H/HeSnJ * C57BL/6	normal integument phenotype	J:109556
Egfrwa2/Egfrwa2 Ptpn11tm1Paw/Ptpn11+ involves: 129S1/Sv * 129X1/SvJ * B6EiC3Sn a/A-Egfrwa2 Wnt3avt * C57BL/6	abnormal breathing pattern	J:75413
	abnormal hair follicle development	J:75413
	abnormal hair follicle morphology	J:75413
	abnormal hair follicle orientation	J:75413
	abnormal hair growth	J:75413
	abnormal intestine morphology	J:75413
	abnormal lung development	J:75413
	abnormal muscle morphology	J:75413
	abnormal skin condition	J:75413
	atelectasis	J:75413
	cachexia	J:75413
	decreased hair follicle number	J:75413
	decreased subcutaneous adipose tissue amount	J:75413
	dry skin	J:75413
	epidermal atrophy	J:75413
	eyelids open at birth	J:75413
	flaky skin	J:75413
	intestinal hypoperistalsis	J:75413
	postnatal growth retardation	J:75413
	postnatal lethality, incomplete penetrance	J:75413
	thick pulmonary interalveolar septum	J:75413
	thin epidermis	J:75413
	thin skin	J:75413
	waved hair	J:75413
Egfrwa2/Egfrwa2 Ptpn11tm1Rbn/Ptpn11+ involves: 129 * B6EiC3Sn-a/A-Egfrwa2 Wnt3avt	abnormal impulse conducting system conduction	J:60750
	aortic valve regurgitation	J:60750
	aortic valve stenosis	J:60750
	congestive heart failure	J:60750
	enlarged semilunar valve	J:60750
	eyelids open at birth	J:60750
	increased left ventricle diastolic pressure	J:60750
	increased left ventricle systolic pressure	J:60750
	increased systemic arterial blood pressure	J:60750
	myocardium hypertrophy	J:60750
	perinatal lethality, incomplete penetrance	J:60750
	prolonged PR interval	J:60750
	prolonged QRS complex duration	J:60750
	prolonged QT interval	J:60750
	prolonged RR interval	J:60750
	prolonged ST segment	J:60750
	thick aortic valve	J:60750
	thick pulmonary valve	J:60750
Egfrwa2/Egfrwa2 Sos1tm1Dlb/Sos1+ involves: 129S1/Sv * 129X1/SvJ * B6EiC3Sn-a/A-Egfrwa2 Wnt3avt	abnormal ciliary body morphology	J:38321
	abnormal cornea morphology	J:38321
	abnormal eye anterior chamber morphology	J:38321
	abnormal lens fiber morphology	J:38321
	abnormal retina morphology	J:38321
	anterior iris synechia	J:38321
	corneal opacity	J:38321
	corneal vascularization	J:38321
	eyelids open at birth	J:38321
	fused cornea and lens	J:38321
	increased cornea thickness	J:38321
	lens vacuoles	J:38321
	microphthalmia	J:38321
	preweaning lethality, incomplete penetrance	J:38321
	small lens	J:38321
EgfrWa5/Egfr+ Tgfatm1Unc/Tgfatm1Unc involves: 129P2/OlaHsd * BALB/cAnN * C3H/HeN * C57BL/6J	postnatal growth retardation	J:92308
	small mandible	J:92308